Paul W. Barone has been at the Massachusetts Institute of Technology’s Center for Biomedical Innovation (CBI) since 2010 where he is currently the Director of the Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB) a pre-competitive biopharmaceutical industry consortium focused on identifying and sharing best practices to mitigate the risk of adventitious agent contamination in biopharmaceutical manufacturing. Dr. Barone is also the Co-Director of Biomanufacturing@MIT-CBI, where he manages a variety of sponsored research activities related to biopharmaceutical manufacturing, including the development of novel analytical technologies for the rapid assessment of protein product quality, the development of a process for the continuous production of viral vectors, and the development of an online course on the principles of cell therapy manufacturing.